ARS Pharmaceuticals (SPRY) Asset Utilization Ratio (2022 - 2026)

ARS Pharmaceuticals (SPRY) has 5 years of Asset Utilization Ratio data on file, last reported at 0.32 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio rose 12.4% year-over-year to 0.32; the trailing twelve-month figure through Mar 2026 stood at 0.32 (up 12.4% YoY), and the FY2025 full-year result was 0.25, down 18.62% from the prior year.
• Asset Utilization Ratio advanced to 0.32 in Q1 2026, from 0.24 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.42 in Q3 2025 to a low of 0.0 in Q1 2024.
• A 5-year average of 0.14 and a median of 0.01 in 2024 frame the typical range for Asset Utilization Ratio.
• Across the five-year window, Asset Utilization Ratio tumbled 98.22% in 2024 and jumped 659486.06% in 2025, its largest moves.
• Tracing SPRY's Asset Utilization Ratio over 5 years: stood at 0.0 in 2022, then tumbled by 97.39% to 0.0 in 2023, then jumped by 251602.23% to 0.31 in 2024, then fell by 23.24% to 0.24 in 2025, then surged by 33.72% to 0.32 in 2026.
• Business Quant data shows SPRY's Asset Utilization Ratio at 0.32 in Q1 2026, 0.24 in Q4 2025, and 0.42 in Q3 2025.